Researchers are unsure why the phenotype is increasing but suggest that more effective treatments may be contributing to the increase in non-albuminuric CKD…. Chronic kidney disease (CKD) is a common complication of diabetes associated with glomerular filtration rate (GFR) loss. Normally, before the GFR loss occurs, albuminuria will be detected. …
Read More »Update: Islet Cell Transplantation for the Treatment of Type 1 Diabetes
Promising trial showed safe restoration of near-normoglycemia in type 1 diabetes…. Islet transplantation is a well-established therapeutic treatment for a subset of patients with difficult to control type 1 diabetes mellitus. Before the Edmonton Protocol, only 9% of the 267 islet transplant recipients since 1999 were insulin independent for more …
Read More »Handbook of Diabetes, 4th Edition, Excerpt #9: Management of Type 1 Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Modern management of type 1 diabetes comprises a package of measures including multiple daily injections for a more physiological insulin replacement; assessment of glycaemic control using blood glucose self-monitoring as well as clinic tests such as glycated haemoglobin (HbA1c); insulin dosage …
Read More »Sensor Implant Measures Blood pH in Type 1 Diabetes
The device, only tested in mice, also can release insulin to prevent acidosis….
Read More »New Way to Regenerate Beta Cells in Type 1 Diabetes
A peptide called caerulein can convert existing cells in the pancreas into insulin-generating beta cells….
Read More »A Link between Cesarean Delivery and Type 1 Diabetes?
Initial findings suggest relationship but with sibling-control analyses, effect almost disappears….
Read More »New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Beta cell encapsulation therapy is a procedure that involves implantation of cells with the ability to secrete insulin in a glucose-responsive manner in a protective barrier into the body…. On July 17th 2014, the Juvenile Diabetes Research Foundation (JDRF) announced that their partner, ViaCyte, Inc. filed an Investigational New Drug …
Read More »Hypoglycemia Awareness improves with Self-Monitoring in Type 1 Diabetes
The best outcomes were achieved by multiple daily injections with self-monitoring of blood glucose….
Read More »Safe and Effective Closed Loop Insulin Delivery for Type 1’s Decreases Hypo’s
A new delivery system has been evaluated and found to be safe and effective for young adults to use at home without any supervision needed….
Read More »New Way to Regenerate Beta Cells in Type 1 Diabetes Patients
A peptide called caerulein converted existing cells in the pancreas into insulin-generating beta cells….
Read More »